SCOPOLAMINE TRANSDE

The Defense Logistics Agency awarded a delivery order under the master contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, with CAGE code 1UNB0, for the procurement of 10,000 scopolamine transdermal patches identified by NSN 6505014562380. The total contract value is $654.80, awarded on July 14, 2026, with delivery required by July 29, 2026. The contract is structured as a single-line-item, fixed-price order with no quantity variance allowed, indicating a precise, non-negotiable requirement. Delivery is FOB destination, with the contractor responsible for freight payment and risk of loss until arrival at the designated location: 5234 Eagle Talon Dr, Bldg X3063, Fort Bragg, NC 28310. Inspection and acceptance occur at the destination by the Government, following standard DoD medical logistics procedures. Packaging and marking must include the NSN, appropriate CAGE codes (1UNB0, 3KJG9, 3V8D7, 96BA9, 8N5B5, 80ED5), and must carry the instruction to ship by the fastest traceable means, explicitly prohibiting parcel post. While no explicit packaging or preservation standards like MIL-STD-129 or MIL-STD-2073 are cited, compliance with DoD medical supply chain norms is implied through the use of standardized identifiers and traceability mandates. The award appears to be based on lowest price technically acceptable criteria given the minor value and lack of complex evaluation factors. Payment is managed under facility code W91KBP with DIC A0A and PR 7017505561, though invoicing procedures and points of contact such as the contracting officer or technical representative are not specified. The contract references ANSI X12 unit-of-issue standards and relies on established DoD pharmaceutical supply protocols, with no supplemental clauses, certifications, or attachments documented in the provided material.